Position in QURE
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$4,341,155
+$2,500,554 QoQ
Shares Held
94,250
-16.3% QoQ
Ownership
0.149%
of shares outstanding
% of Portfolio
0.49%
of 13F equity value
Holder Rank
#81
of 255 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in QURE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Pekin Hardy Strauss, Inc. holds $8,527,428 across 8 Biotechnology names. QURE ranks #1 (50.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | QURE |
uniQure N.V.
This page
|
94,250 | $4,341,155 | |
| 2 | TWST |
Twist Bioscience Corp
|
23,400 | $2,407,392 | |
| 3 | ARDX |
Ardelyx, Inc.
|
226,400 | $1,154,640 | |
| 4 | CRMD |
CorMedix Inc.
|
54,000 | $423,900 | |
| 5 | GALT |
Galectin Therapeutics Inc
|
30,000 | $139,200 | |
| 6 | DYAI |
Dyadic International Inc
|
41,745 | $37,570 | |
| 7 | CRBU |
Caribou Biosciences, Inc.
|
10,000 | $17,600 | |
| 8 | HRTX |
Heron Therapeutics, Inc. /De/
|
13,992 | $5,971 |
All Filings in QURE
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,341,155 | 94,250 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $1,840,601 | 112,575 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $701,149 | 29,300 | Shares | Sole | 2026-01-30 | |
| No filing history on record for this holder in this stock. | ||||||